HDFC Mutual Fund sold 2,69,92,907 equity shares of Piramal Pharma Limited through an open-market transaction on October 28, 2026. The shares sold represent 2.027% of the company's total paid-up equity share capital.
Before the transaction, HDFC Mutual Fund held 9,33,93,655 shares, representing a 7.015% stake in Piramal Pharma. Following the sale, its shareholding declined to 6,64,00,748 shares, equivalent to 4.988% of the company's paid-up equity share capital.
HDFC Mutual Fund Schemes Involved
The shares were held across multiple schemes of HDFC Mutual Fund. The disclosure lists the following schemes:
- HDFC BSE 500 ETF
- HDFC BSE 500 Index Fund
- HDFC Flexi Cap Fund
- HDFC NIFTY500 MULTICAP 50:25:25 Index Fund
- HDFC Nifty Smallcap 250 ETF
- HDFC Nifty Smallcap 250 Index Fund
HDFC Trustee Company Limited is also mentioned in the disclosure as part of the acquiring entity details.
HDFC Mutual Fund Piramal Pharma Stake Sale Highlights
| Particulars | Details |
| Company | Piramal Pharma Limited |
| Investor | HDFC Mutual Fund |
| Transaction | Sale of equity shares |
| Shares Sold | 2,69,92,907 shares |
| Stake Sold | 2.027% |
| Transaction Date | October 28, 2026 |
| Mode of Transaction | Open Market |
| Shareholding Before Sale | 9,33,93,655 shares |
| Stake Before Sale | 7.015% |
| Shareholding After Sale | 6,64,00,748 shares |
| Stake After Sale | 4.988% |
| Disclosure Filed By | HDFC Asset Management Company Limited |
| Regulation | SEBI Regulation 29(2) |
What to Watch Next
- Investors may track further shareholding disclosures from HDFC Mutual Fund to monitor any additional changes in its investment in Piramal Pharma.
- Market participants can also monitor future shareholding patterns and stock exchange filings of Piramal Pharma for updates on institutional ownership.
- The reduction in HDFC Mutual Fund's stake below 5% is another development to monitor while tracking changes in the company's shareholding structure.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Mirae Asset Mutual Fund Sells 0.98% Stake in TeamLease Services
Mirae Asset Mutual Fund has sold 1,49,729 shares of TeamLease Services Limited through an open market transaction, reducing its stake in the company from 6.38% to 5.40%. Following the sale, the fund holds 8,25,414 shares in the staffing and human resource services company. The transaction was disclosed in a regulatory filing dated October 27, 2026.
SBI Mutual Fund Acquires 5.25% Stake in ASM Technologies
SBI Mutual Fund has acquired a 5.25% stake in ASM Technologies Limited through a preferential allotment of equity shares. SBI Mutual Fund acquired 8,22,564 equity shares of the company, which were allotted on October 16, 2026. Following the allotment, its shareholding in ASM Technologies increased to 5.2501% of the company's paid-up share capital. The acquisition was made across various schemes of SBI Mutual Fund. The disclosure was submitted by SBI Funds Management Limited under Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
India Max Investment Fund Acquires 6.06% Stake in Liqvd Digital
India Max Investment Fund Limited has acquired 13,50,000 equity shares of Liqvd Digital Limited through open market purchases on October 16, 2026. The acquisition represents a 6.06% stake in the company, taking the fund’s shareholding from zero to over 6% and triggering disclosure requirements under SEBI’s takeover regulations.